Bio-Techne Corporation (TECH)
USD 50.06
(-3.21%)
USD 50.06
(-3.21%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 1.15 Billion USD | 1.97% |
| 2023 | 1.13 Billion USD | 2.81% |
| 2022 | 1.1 Billion USD | 18.75% |
| 2021 | 931.03 Million USD | 26.04% |
| 2020 | 738.69 Million USD | 3.46% |
| 2019 | 714 Million USD | 11.04% |
| 2018 | 642.99 Million USD | 14.21% |
| 2017 | 563 Million USD | 12.82% |
| 2016 | 499.02 Million USD | 10.34% |
| 2015 | 452.24 Million USD | 26.41% |
| 2014 | 357.76 Million USD | 15.19% |
| 2013 | 310.57 Million USD | -1.27% |
| 2012 | 314.56 Million USD | 8.48% |
| 2011 | 289.96 Million USD | 7.77% |
| 2010 | 269.04 Million USD | 1.93% |
| 2009 | 263.95 Million USD | 2.54% |
| 2008 | 257.42 Million USD | 15.19% |
| 2007 | 223.48 Million USD | 10.3% |
| 2006 | 202.61 Million USD | 13.41% |
| 2005 | 178.65 Million USD | 10.79% |
| 2004 | 161.25 Million USD | 11.2% |
| 2003 | 145.01 Million USD | 10.78% |
| 2002 | 130.9 Million USD | 13.47% |
| 2001 | 115.35 Million USD | 11.09% |
| 2000 | 103.83 Million USD | 14.23% |
| 1999 | 90.9 Million USD | 35.07% |
| 1998 | 67.3 Million USD | 10.51% |
| 1997 | 60.9 Million USD | 11.54% |
| 1996 | 54.6 Million USD | 14.47% |
| 1995 | 47.7 Million USD | 18.36% |
| 1994 | 40.3 Million USD | 40.42% |
| 1993 | 28.7 Million USD | 28.7% |
| 1992 | 22.3 Million USD | 15.54% |
| 1991 | 19.3 Million USD | 22.93% |
| 1990 | 15.7 Million USD | 25.6% |
| 1989 | 12.5 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 272.59 Million USD | -1.57% |
| 2024 Q1 | 276.93 Million USD | -8.09% |
| 2024 Q3 | 303.42 Million USD | 11.31% |
| 2024 Q4 | 306.09 Million USD | 0.88% |
| 2024 FY | 1.15 Billion USD | 1.97% |
| 2023 FY | 1.13 Billion USD | 2.81% |
| 2023 Q1 | 269.65 Million USD | -6.44% |
| 2023 Q2 | 271.58 Million USD | 0.71% |
| 2023 Q4 | 301.32 Million USD | 2.44% |
| 2023 Q3 | 294.14 Million USD | 8.31% |
| 2022 Q3 | 290.37 Million USD | 7.84% |
| 2022 Q4 | 288.22 Million USD | -0.74% |
| 2022 FY | 1.1 Billion USD | 18.75% |
| 2022 Q2 | 269.27 Million USD | 4.48% |
| 2022 Q1 | 257.71 Million USD | -0.51% |
| 2021 Q3 | 243.55 Million USD | 8.61% |
| 2021 Q4 | 259.02 Million USD | 6.35% |
| 2021 Q1 | 204.19 Million USD | 16.13% |
| 2021 Q2 | 224.25 Million USD | 9.82% |
| 2021 FY | 931.03 Million USD | 26.04% |
| 2020 Q4 | 175.83 Million USD | -9.68% |
| 2020 Q1 | 183.24 Million USD | -4.39% |
| 2020 Q2 | 184.93 Million USD | 0.92% |
| 2020 Q3 | 194.68 Million USD | 5.27% |
| 2020 FY | 738.69 Million USD | 3.46% |
| 2019 FY | 714 Million USD | 11.04% |
| 2019 Q1 | 162.97 Million USD | -9.59% |
| 2019 Q4 | 191.66 Million USD | 3.68% |
| 2019 Q3 | 184.86 Million USD | 5.93% |
| 2019 Q2 | 174.51 Million USD | 7.08% |
| 2018 Q1 | 144.61 Million USD | -7.64% |
| 2018 FY | 642.99 Million USD | 14.21% |
| 2018 Q4 | 180.25 Million USD | 9.93% |
| 2018 Q3 | 163.97 Million USD | 6.37% |
| 2018 Q2 | 154.15 Million USD | 6.6% |
| 2017 Q2 | 131.8 Million USD | 0.94% |
| 2017 Q3 | 144.03 Million USD | 9.28% |
| 2017 Q1 | 130.58 Million USD | -3.1% |
| 2017 FY | 563 Million USD | 12.82% |
| 2017 Q4 | 156.57 Million USD | 8.71% |
| 2016 Q1 | 112.38 Million USD | -4.49% |
| 2016 FY | 499.02 Million USD | 10.34% |
| 2016 Q2 | 120.9 Million USD | 7.59% |
| 2016 Q4 | 134.76 Million USD | 2.89% |
| 2016 Q3 | 130.97 Million USD | 8.33% |
| 2015 Q3 | 114.15 Million USD | 1.97% |
| 2015 FY | 452.24 Million USD | 26.41% |
| 2015 Q4 | 117.66 Million USD | 3.07% |
| 2015 Q2 | 111.94 Million USD | 3.2% |
| 2015 Q1 | 108.47 Million USD | 17.24% |
| 2014 Q1 | 85.66 Million USD | 7.79% |
| 2014 Q2 | 84.01 Million USD | -1.93% |
| 2014 FY | 357.76 Million USD | 15.19% |
| 2014 Q4 | 92.52 Million USD | -3.17% |
| 2014 Q3 | 95.55 Million USD | 13.73% |
| 2013 FY | 310.57 Million USD | -1.27% |
| 2013 Q4 | 79.47 Million USD | -1.87% |
| 2013 Q3 | 80.99 Million USD | 7.87% |
| 2013 Q2 | 75.08 Million USD | 0.08% |
| 2013 Q1 | 75.02 Million USD | -4.65% |
| 2012 Q1 | 77.59 Million USD | -0.57% |
| 2012 Q3 | 83.62 Million USD | 12.0% |
| 2012 Q2 | 74.66 Million USD | -3.78% |
| 2012 Q4 | 78.68 Million USD | -5.91% |
| 2012 FY | 314.56 Million USD | 8.48% |
| 2011 Q4 | 78.03 Million USD | 2.32% |
| 2011 FY | 289.96 Million USD | 7.77% |
| 2011 Q1 | 67.94 Million USD | 1.85% |
| 2011 Q2 | 67.7 Million USD | -0.35% |
| 2011 Q3 | 76.27 Million USD | 12.65% |
| 2010 Q1 | 66.53 Million USD | 2.53% |
| 2010 FY | 269.04 Million USD | 1.93% |
| 2010 Q4 | 66.71 Million USD | -5.07% |
| 2010 Q3 | 70.27 Million USD | 7.26% |
| 2010 Q2 | 65.52 Million USD | -1.52% |
| 2009 Q2 | 61.87 Million USD | -10.74% |
| 2009 Q3 | 67.86 Million USD | 9.68% |
| 2009 Q4 | 64.89 Million USD | -4.39% |
| 2009 FY | 263.95 Million USD | 2.54% |
| 2009 Q1 | 69.32 Million USD | 2.29% |
| 2008 FY | 257.42 Million USD | 15.19% |
| 2008 Q3 | 69.52 Million USD | 11.88% |
| 2008 Q1 | 57.98 Million USD | -0.75% |
| 2008 Q2 | 62.14 Million USD | 7.17% |
| 2008 Q4 | 67.76 Million USD | -2.52% |
| 2007 Q4 | 58.42 Million USD | -2.94% |
| 2007 FY | 223.48 Million USD | 10.3% |
| 2007 Q3 | 60.19 Million USD | 14.64% |
| 2007 Q2 | 52.5 Million USD | 0.3% |
| 2007 Q1 | 52.35 Million USD | 0.55% |
| 2006 Q2 | 48.02 Million USD | 0.67% |
| 2006 Q1 | 47.7 Million USD | 0.33% |
| 2006 FY | 202.61 Million USD | 13.41% |
| 2006 Q4 | 52.06 Million USD | -5.01% |
| 2006 Q3 | 54.81 Million USD | 14.12% |
| 2005 Q1 | 40.91 Million USD | -3.63% |
| 2005 FY | 178.65 Million USD | 10.79% |
| 2005 Q2 | 42.24 Million USD | 3.25% |
| 2005 Q4 | 47.55 Million USD | -0.8% |
| 2005 Q3 | 47.93 Million USD | 13.46% |
| 2004 Q1 | 37.99 Million USD | -3.63% |
| 2004 Q3 | 42.54 Million USD | 11.18% |
| 2004 Q4 | 42.45 Million USD | -0.19% |
| 2004 Q2 | 38.26 Million USD | 0.71% |
| 2004 FY | 161.25 Million USD | 11.2% |
| 2003 Q4 | 39.42 Million USD | 4.48% |
| 2003 Q3 | 37.73 Million USD | 13.32% |
| 2003 FY | 145.01 Million USD | 10.78% |
| 2003 Q1 | 34.54 Million USD | -3.05% |
| 2003 Q2 | 33.3 Million USD | -3.61% |
| 2002 FY | 130.9 Million USD | 13.47% |
| 2002 Q1 | 29.84 Million USD | -2.81% |
| 2002 Q2 | 31.13 Million USD | 4.34% |
| 2002 Q3 | 34.28 Million USD | 10.11% |
| 2002 Q4 | 35.63 Million USD | 3.94% |
| 2001 FY | 115.35 Million USD | 11.09% |
| 2001 Q4 | 30.7 Million USD | 1.54% |
| 2001 Q3 | 30.24 Million USD | 13.31% |
| 2001 Q2 | 26.68 Million USD | -3.73% |
| 2001 Q1 | 27.72 Million USD | 1.49% |
| 2000 Q3 | 26.77 Million USD | 6.68% |
| 2000 Q1 | 24.6 Million USD | 1.23% |
| 2000 Q2 | 25.1 Million USD | 2.03% |
| 2000 FY | 103.83 Million USD | 14.23% |
| 2000 Q4 | 27.31 Million USD | 2.0% |
| 1999 Q4 | 24.3 Million USD | 2.1% |
| 1999 Q3 | 23.8 Million USD | 10.7% |
| 1999 FY | 90.9 Million USD | 35.07% |
| 1999 Q2 | 21.5 Million USD | 0.94% |
| 1999 Q1 | 21.3 Million USD | 14.52% |
| 1998 Q4 | 18.6 Million USD | 5.08% |
| 1998 Q3 | 17.7 Million USD | 14.19% |
| 1998 Q2 | 15.5 Million USD | 0.0% |
| 1998 Q1 | 15.5 Million USD | -4.32% |
| 1998 FY | 67.3 Million USD | 10.51% |
| 1997 Q1 | 14 Million USD | -4.11% |
| 1997 FY | 60.9 Million USD | 11.54% |
| 1997 Q2 | 14.4 Million USD | 2.86% |
| 1997 Q3 | 16.3 Million USD | 13.19% |
| 1997 Q4 | 16.2 Million USD | -0.61% |
| 1996 FY | 54.6 Million USD | 14.47% |
| 1996 Q4 | 14.6 Million USD | -0.68% |
| 1996 Q3 | 14.7 Million USD | 17.6% |
| 1996 Q1 | 12.8 Million USD | 0.0% |
| 1996 Q2 | 12.5 Million USD | -2.34% |
| 1995 Q1 | 11 Million USD | 0.92% |
| 1995 Q2 | 11.4 Million USD | 3.64% |
| 1995 Q3 | 12.6 Million USD | 10.53% |
| 1995 Q4 | 12.8 Million USD | 1.59% |
| 1995 FY | 47.7 Million USD | 18.36% |
| 1994 Q1 | 9.4 Million USD | 22.08% |
| 1994 FY | 40.3 Million USD | 40.42% |
| 1994 Q3 | 11 Million USD | 22.22% |
| 1994 Q4 | 10.9 Million USD | -0.91% |
| 1994 Q2 | 9 Million USD | -4.26% |
| 1993 FY | 28.7 Million USD | 28.7% |
| 1993 Q1 | 6.3 Million USD | 0.0% |
| 1993 Q2 | 6.9 Million USD | 9.52% |
| 1993 Q3 | 7.8 Million USD | 13.04% |
| 1993 Q4 | 7.7 Million USD | -1.28% |
| 1992 Q4 | 6.3 Million USD | 6.78% |
| 1992 Q3 | 5.9 Million USD | 20.41% |
| 1992 Q2 | 4.9 Million USD | -5.77% |
| 1992 FY | 22.3 Million USD | 15.54% |
| 1992 Q1 | 5.2 Million USD | 1.96% |
| 1991 Q2 | 4.8 Million USD | 20.0% |
| 1991 Q4 | 5.1 Million USD | -5.56% |
| 1991 Q1 | 4 Million USD | -6.98% |
| 1991 Q3 | 5.4 Million USD | 12.5% |
| 1991 FY | 19.3 Million USD | 22.93% |
| 1990 FY | 15.7 Million USD | 25.6% |
| 1990 Q4 | 4.3 Million USD | 4.88% |
| 1990 Q2 | 4.1 Million USD | 28.13% |
| 1990 Q3 | 4.1 Million USD | 0.0% |
| 1990 Q1 | 3.2 Million USD | 0.0% |
| 1989 FY | 12.5 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -2948.153% |
| Alkermes plc | 1.66 Billion USD | 30.32% |
| Agenus Inc. | 156.31 Million USD | -641.495% |
| Aptorum Group Limited | 431.37 Thousand USD | -268587.787% |
| Ardelyx, Inc. | 124.45 Million USD | -831.301% |
| Dyadic International, Inc. | 2.89 Million USD | -39884.049% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -3563.043% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -444836.66% |
| Novavax, Inc. | 983.7 Million USD | -17.826% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -14239.478% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -5984.624% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -11565.258% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -144421.197% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | -607.115% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -13990.202% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -5484.217% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | 36.604% |
| AlloVir, Inc. | - USD | -Infinity% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -381.467% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -273263.208% |
| Bicycle Therapeutics plc | 26.97 Million USD | -4196.634% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -83889.855% |
| ChromaDex Corporation | 83.57 Million USD | -1286.933% |
| Chimerix, Inc. | 324 Thousand USD | -357634.568% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -3261.835% |
| CRISPR Therapeutics AG | 371.2 Million USD | -212.242% |
| Precision BioSciences, Inc. | 48.72 Million USD | -2278.681% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -1724.343% |
| Fortress Biotech, Inc. | 84.51 Million USD | -1271.458% |
| Fortress Biotech, Inc. | 84.51 Million USD | -1271.458% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -5658.16% |
| ImmuCell Corporation | 17.47 Million USD | -6533.94% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -4856.425% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 3.69 Billion USD | 68.637% |
| Innoviva, Inc. | 310.46 Million USD | -273.333% |
| IO Biotech, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 9.76 Million USD | -11774.398% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -767489.404% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -782.663% |
| ContextLogic Inc. | 287 Million USD | -303.854% |
| MiMedx Group, Inc. | 321.47 Million USD | -260.542% |
| MEI Pharma, Inc. | 65.29 Million USD | -1675.059% |
| NextCure, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 58.46 Thousand USD | -1982385.248% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -147550.955% |
| Opthea Limited | 261.85 Thousand USD | -442527.521% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -18519.438% |
| Pharming Group N.V. | 245.31 Million USD | -372.476% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -169850.147% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -2607.452% |
| PureTech Health plc | 3.33 Million USD | -34706.607% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -891.65% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -12024.059% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | -557.69% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -74485.586% |
| Acelyrin, Inc. | - USD | -Infinity% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -45158.102% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -13101.139% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -23181100.0% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -798.406% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -108834.211% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -922.956% |
| Seer, Inc. | 15.18 Million USD | -7534.436% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -22520.219% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -4659.218% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 10 Thousand USD | -11590500.0% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -64292.222% |
| Akebia Therapeutics, Inc. | 194.62 Million USD | -495.541% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | -191.072% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -41894.928% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -1744.491% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -9522.748% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -137988.708% |
| Century Therapeutics, Inc. | 2.23 Million USD | -51759.508% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -5406.485% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -1045.158% |
| Autolus Therapeutics plc | 1.69 Million USD | -68160.306% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -2418.71% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -1704400.0% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | -580.695% |
| GRI Bio, Inc. | 21.76 Million USD | -5224.85% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -45532.535% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -54315.962% |
| INmune Bio, Inc. | 155 Thousand USD | -747680.645% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -812.33% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -51667.068% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -115806.0% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -13419.888% |
| Coherus BioSciences, Inc. | 257.24 Million USD | -350.568% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -33016.0% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -73258.228% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -14820.958% |
| Histogen Inc. | 3.76 Million USD | -30652.454% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -198630.863% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -1063257.798% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -295808.807% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -3321.175% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -16813.177% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | -634.754% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -794865.706% |
| Apollomics, Inc. | 821 Thousand USD | -141076.614% |
| Amarin Corporation plc | 306.91 Million USD | -277.653% |
| Mesoblast Limited | 5.9 Million USD | -19538.428% |
| Turnstone Biologics Corp. | 19.3 Million USD | -5903.626% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -1374.781% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | -560.384% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.83 Billion USD | 36.671% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -1405.527% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | -192.256% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -86981.893% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -728.427% |
| Insmed Incorporated | 305.2 Million USD | -279.761% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -6102.826% |
| OmniAb, Inc. | 34.16 Million USD | -3292.636% |
| Alector, Inc. | 97.06 Million USD | -1094.144% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -817.522% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -1125200.971% |
| Zai Lab Limited | 266.71 Million USD | -334.562% |
| Revance Therapeutics, Inc. | 234.04 Million USD | -395.24% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -891484.615% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -6543.32% |
| Veracyte, Inc. | 361.05 Million USD | -221.024% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -25109.397% |
| FibroGen, Inc. | 147.75 Million USD | -684.463% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -784081.861% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | 69.771% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -275866.667% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | -204.386% |
| TG Therapeutics, Inc. | 233.66 Million USD | -396.041% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | 62.719% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -74294.095% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -3293.529% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -1266.51% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -1918.424% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | -166.911% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -2489.731% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | -249.734% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -2100407.43% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -4357.237% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -12878344.444% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -34904.936% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | 91.164% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -949077.804% |
| Pluri Inc. | 326 Thousand USD | -355439.877% |
| Prothena Corporation plc | 91.37 Million USD | -1168.535% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -1822.762% |
| Celularity Inc. | 22.77 Million USD | -4990.071% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -21012.204% |
| MeiraGTx Holdings plc | 14.01 Million USD | -8168.959% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | -364.687% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -1713.723% |
| Blueprint Medicines Corporation | 249.38 Million USD | -364.777% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -3640.23% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -15781.885% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -3095.203% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -23101.371% |
| Cytokinetics, Incorporated | 7.53 Million USD | -15292.563% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -55482.037% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -828.771% |
| Evogene Ltd. | 5.64 Million USD | -20450.709% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -11498.719% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -12358.992% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -24047.083% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -3073.16% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -369027.389% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -57853.0% |
| MediciNova, Inc. | 1 Million USD | -115806.0% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -47266.571% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -6791930.472% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | -328.33% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | -23.591% |
| Mereo BioPharma Group plc | 10 Million USD | -11490.6% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -20170.374% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -5493.109% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | -328.87% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -41221.212% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | -140.282% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -1219963.158% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -24260.235% |
| Kezar Life Sciences, Inc. | 7 Million USD | -16458.0% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -5427.757% |
| aTyr Pharma, Inc. | 353 Thousand USD | -328245.609% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -7363.842% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -369027.389% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -9611476.416% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | -39.772% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -512286.83% |
| UroGen Pharma Ltd. | 82.71 Million USD | -1301.303% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -653.953% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -4191798.734% |
| Orgenesis Inc. | 530 Thousand USD | -218590.566% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | -588.531% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -456991.252% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | -501.672% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -512286.83% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -6791930.472% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -77016.434% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -22169.252% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -10476.33% |
| scPharmaceuticals Inc. | 13.59 Million USD | -8426.889% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -11464.003% |
| Daré Bioscience, Inc. | 2.8 Million USD | -41178.756% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -629823.913% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | 52.86% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -9909.154% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -1831.767% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -3829.417% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | 52.09% |
| DBV Technologies S.A. | 15.72 Million USD | -7269.405% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | 83.074% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -14377.392% |
| Molecular Templates, Inc. | 57.3 Million USD | -1922.581% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -698.042% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -11388.354% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -16739.46% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -1872.902% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -179550.204% |
| Adagene Inc. | 18.11 Million USD | -6299.584% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -107021.996% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | -301.135% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | -363.609% |
| SciSparc Ltd. | 2.87 Million USD | -40159.118% |
| Vericel Corporation | 197.51 Million USD | -486.818% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -19531.775% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -1844.536% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -4437.149% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -1098.181% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -1054.592% |
| ADMA Biologics, Inc. | 258.21 Million USD | -348.874% |
| Clene Inc. | 654 Thousand USD | -177126.3% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -4503.451% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -2500.247% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -2218.12% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -1083133.645% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -1244.929% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -1585221.151% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -1883.232% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -9757.629% |
| Trevena, Inc. | 3.12 Million USD | -36989.92% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | -59.554% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -18332.888% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -14616.353% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -186244.051% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -21198.42% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -1552.424% |
| Celularity Inc. | 22.77 Million USD | -4990.071% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -28782.631% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -740896.938% |
| Cibus, Inc. | 1.81 Million USD | -63689.763% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -32096.111% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -16081.209% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -60142.204% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | -47.155% |
| Eyenovia, Inc. | 3787.00 USD | -30606184.658% |
| Puma Biotechnology, Inc. | 235.63 Million USD | -391.884% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -950.644% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -237412.295% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -1363.386% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -127965.994% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| Geron Corporation | 237 Thousand USD | -488954.852% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -17023.061% |
| Royalty Pharma plc | 2.35 Billion USD | 50.774% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -157837.839% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -3044.919% |
| Humacyte, Inc. | - USD | -Infinity% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -681700.0% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -96167.442% |
| Notable Labs, Ltd. | 310 Thousand USD | -373790.323% |
| Liquidia Corporation | 17.48 Million USD | -6527.745% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -107021.996% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -6289.174% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -62148.12% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -67578.581% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | 50.202% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -1607428.224% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -24260.235% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -3863433.333% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -7215.912% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -1691.354% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -271979.812% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | -190.232% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -3364.12% |
| Peak Bio, Inc. | 367.87 Thousand USD | -314967.264% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -4120.749% |
| Benitec Biopharma Inc. | 216 Thousand USD | -536501.852% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -130719.413% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | 5.484% |
| Immunome, Inc. | 14.01 Million USD | -8168.369% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -69849.306% |
| CervoMed Inc. | 7.14 Million USD | -16122.264% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -23491.696% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -40914.154% |
| Moolec Science SA | 905.04 Thousand USD | -127965.994% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -139208.422% |
| AnaptysBio, Inc. | 17.15 Million USD | -6655.61% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -47015.322% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -52512.801% |
| Lumos Pharma, Inc. | 2.05 Million USD | -56411.945% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -2746.052% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -55482.037% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -568066.667% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -965783.333% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -463524.0% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | -206.866% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | -521.9% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -2797.65% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -97381.918% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -7401.521% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -203243.86% |
| HCW Biologics Inc. | 2.84 Million USD | -40686.208% |
| XOMA Corporation | 4.75 Million USD | -24260.235% |
| Nektar Therapeutics | 90.12 Million USD | -1186.101% |
| Arvinas, Inc. | 78.5 Million USD | -1376.51% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -2537.404% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -37361.538% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -177126.3% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -66094.175% |
| Synlogic, Inc. | 3.37 Million USD | -34283.269% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -314967.264% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -5711.864% |
| Krystal Biotech, Inc. | 50.69 Million USD | -2186.159% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -693.697% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -21178.869% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -257688.295% |
| MannKind Corporation | 198.96 Million USD | -482.553% |
| Ikena Oncology, Inc. | 9.16 Million USD | -12553.493% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -921.648% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | -306.484% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -28976400.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -2210.956% |
| REGENXBIO Inc. | 90.24 Million USD | -1184.391% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -51863.668% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -15607.548% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -153417.881% |
| Longeveron Inc. | 709 Thousand USD | -163378.138% |
| Repare Therapeutics Inc. | 51.13 Million USD | -2166.755% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | 6.778% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -9909.154% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -551833.333% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | 88.256% |
| Denali Therapeutics Inc. | 330.53 Million USD | -250.666% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -7012.125% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -42780.503% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -1396.952% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -760288.375% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -7669.019% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -171612.593% |
| OmniAb, Inc. | 34.16 Million USD | -3292.636% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -5353.887% |
| Lipocine Inc. | -2.85 Million USD | 40757.103% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -51667.068% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -1304.734% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -1240.651% |
| Ocugen, Inc. | 6.03 Million USD | -19102.452% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -100164.706% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -3112.116% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -19210.567% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -182976.345% |
| Dominari Holdings Inc. | 2.03 Million USD | -56744.532% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -4221.142% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | -99.144% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -9102.541% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -242889.518% |
| Iterum Therapeutics plc | - USD | -Infinity% |